Abeyance Cryogenic LN2 Vapor Cryo Freezer and Racks
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Cancer Institute at the National Institutes of Health intends to award a sole-source firm-fixed-price purchase order to Lab Rep Co. for Abeyance Cryogenic LN2 Vapor Cryo Freezers and associated racks to replace aging equipment in the Pediatric Oncology Branch. The requirement demands units that match the exact footprint of existing freezers due to limited floor space, while offering increased storage capacity, advanced touchscreen controls, remote data monitoring via cloud or USB, and enhanced safety features such as cryogenic LED lighting, automatic fog-clear, low-profile access, and hinged lids. The system must provide reliable -190°C vapor-phase storage with extended hold times, dual monitoring of temperature and liquid nitrogen levels, battery backup, gas bypass, and integrated ducting to minimize vapor exposure and condensation. These freezers are specifically chosen because the prior model, the Azenta A440, has proven exceptional reliability, performance, and compatibility with current workflows and infrastructure, making it the only suitable replacement to ensure uninterrupted preservation of critical clinical and research samples. The sole-source justification is grounded in the proven track record of the Abeyance A440 freezer and the necessity to maintain consistency across the inventory to avoid operational disruption or sample loss. The acquisition is authorized under FAR 13.106-1(b)(1)(i), which permits single-source procurement when only one vendor can meet the government’s specific needs. While this notice is not a request for proposals, interested parties may submit capability statements by August 12, 2026, at 3:00 PM Eastern Time to the designated point of contact, Claudia Ventola, for consideration, though the government retains full discretion to proceed without competition. All submissions must reference the notice ID number 75N98026Q00659 NCI and be emailed to Claudia.Ventola@hhs.gov. The equipment will be delivered to and installed at the NIH campus in Bethesda, Maryland, under the oversight of the Office of Acquisition Management Services within the U.S. Department of Health and Human Services.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
NOTICE OF INTENT to Sole Source
NOTICE ID NUMBER: 75N98026Q00659 NCI
TITLE:
Abeyance Cryogenic LN2 Vapor Cryo Freezer and Racks
CLASSIFICATION CODE:
6640 – Laboratory Equipment and Supplies
NAICS CODE:
334516 – Analytical Laboratory Instrument Manufacturing
RESPONSE DATE:
August 12, 2026 – 3 PM
The National Institutes of Health (NIH) National Cancer Institute (NCI) intends to award a sole-source firm-fixed-price purchase order to Lab Rep Co. for an Abeyance Cryogenic LN2 Vapor Cryo Freezer and racks.
Requirement
The Pediatric Oncology Branch (POB) of the National Cancer Institute (NCI) at NIH maintains several liquid nitrogen freezers used for long-term storage of critical clinical and research samples.
The following product features/characteristics are required for this requirement:
• Optimized design for size/capacity/usability
• Touchscreen controller automatically maintains freezer conditions
• Critical data is recorded (can be pushed to the cloud, emailed or saved to USB drive)
• Supports independent temperature and liquid nitrogen level monitoring and control
• Increased capacity while maintaining footprint size of current units to optimize restricted space
• Cryogenic LED and automatic fog-clear to enhance visibility and sample access
• Improved ergonomics allowing for safer/easier access to samples
• Cryogenic freezers must fit in space currently occupied by the units being replaced as floor space is limited.
Sole-Source Rationale
The Pediatric Oncology Branch (POB) of the National Cancer Institute (NCI) at NIH has been systematically replacing aging liquid nitrogen freezers as they reach the end of their operational lifespan in order to mitigate the risk of catastrophic equipment failure and potential loss of critical clinical and research samples. The most recent replacement units were purchased several years ago.
Those units—the Abeyance A440 liquid nitrogen freezers from Azenta Life Sciences—have demonstrated excellent reliability, performance, and compatibility with the Branch’s current storage infrastructure. Based on this positive operational experience, the Abeyance A440 has proven to be a dependable solution for the long-term storage of valuable biological samples and represents an appropriate replacement platform as older units continue to malfunction and be retired.
The Azenta A440 Cryo freezer is a secure cryo freezer designed for samples specifically with user feedbacks over the years.
i. -190°C vapor storage with extended hold times resulting in the most energy efficient system per sample
ii. Unique design offers increased capacity resulting in 10-30% more samples stored
iii. Improved ergonomics/sample access and workflow
a. Cryo LED and auto fog clear system for full visibility
b. Large folding step and safety handle
c. Low profile liftover height
d. Hinged lid
iv. Monitor system for easy access to data to review performance graphs, export data and log/schedule maintenance
v. Cloud-based controller with remote monitoring
vi. Data can be directly emailed, pushed to the cloud or saved directly to USB flash drive
vii. Supports secondary temperature and LN-level monitoring
viii. Ductwork vents LN2 vapor away from lid to reduce user exposer as well as minimizing condensation
ix. Battery backup and gas bypass
x. Onboard installation checklist to ensure proper and safe setup
Authority
The intended sole-source acquisition is authorized under Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i), which permits solicitation from a single source when the Contracting Officer determines that only one source is reasonably available for an acquisition not exceeding the Simplified Acquisition Threshold.
Capability Statements
This notice is not a request for quotations or proposals. However, responsible sources that believe they can satisfy the Government's requirement may submit a written capability statement. The Government will evaluate all capability statements received; however, the determination not to compete this requirement remains solely within the Government's discretion.
Submission Instructions
Capability statements shall reference Notice ID number NIH-NCI-NOI- 75N98026Q00659
and must be submitted electronically no later than August 12, 2026, at36:00 P.M. Eastern Time (ET). to Claudia.Ventola@hhs.gov
POINT OF CONTACT:
Claudia Ventola, Contract Specialist
Office of Acquisition Management Services
Office of the Assistant Secretary for Administration
U.S. Department of Health and Human Services
Claudia.Ventola@hhs.gov
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → Omas Strategic Buying Center - Professional Services
Same awarding agency